Beatrice Uziely

6.2k citations
83 papers · 4.6k indexed · 2 hit papers · h-index 28

Beatrice Uziely

81 papers receiving 4.4k citations

Hit Papers

Phase II study of liposomal doxorubicin in refractory ova...51319942026200420152505007501000

Peers

Beatrice Uziely
Comparison fields: 5 of 146
  • Biomaterials 1.1k
  • Reproductive Medicine 492
  • Oncology 1.5k
  • Cancer Research 583
  • Hematology 427
Replace Tamar Peretz with:
Tamar Peretz Israel
Raphael Catane Israel
Rebecca L. Stone United States
Moshe Inbar Israel
Fray F. Marshall United States
Alexander Eggermont Netherlands
Christoph Rochlitz Switzerland
Michael V. Seiden United States
Stefano Ferrari Italy
Olivier Trédan France
Beatrice Uziely relative to Tamar Peretz Israel Tamar Peretz's profile →
Citations per field
00.5×3.6×
Tamar Peretz · 1×
Citations per year

Countries citing papers authored by Beatrice Uziely

Since Specialization
Citations

This map shows the geographic impact of Beatrice Uziely's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beatrice Uziely with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beatrice Uziely more than expected).

Fields of papers citing papers by Beatrice Uziely

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beatrice Uziely. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beatrice Uziely. The network helps show where Beatrice Uziely may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Beatrice Uziely, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Beatrice Uziely Line = papers co-authored together Beatrice Uziely links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20223
2 20194
3 201923
4 201814
5 201711
6 20161
7 201617
8 201611
9 20161
10 201527
11 201429
12 201418
13 201315
14 201027
15 2009161
16 200435
17 200357
18 1994129
19 199312
20 199314

About Beatrice Uziely

Beatrice Uziely is a scholar working on Cancer Research, Immunology and Allergy and Oncology, having authored 83 papers that have together received 4.6k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (13 papers), Blood Coagulation and Thrombosis Mechanisms (12 papers), Childhood Cancer Survivors' Quality of Life (9 papers), Cancer Treatment and Pharmacology (9 papers), Cell Adhesion Molecules Research (9 papers), Family Support in Illness (7 papers), Protease and Inhibitor Mechanisms (7 papers) and Cancer Genomics and Diagnostics (7 papers). The work is most often cited by research in Biomaterials (1.1k citations), Reproductive Medicine (492 citations) and Oncology (1.5k citations). Beatrice Uziely has collaborated with scholars based in Israel, United States and Netherlands. Frequent co-authors include Alberto Gabizón, Raphael Catane, Tamar Safra, Francisco J. Plaza Martín, Anthony H. C. Huang, Y. Barenholz, Rivka Cohen, Bela Kaufman, Rachel Bar‐Shavit and Franco M. Muggia. Their work appears in journals such as Nature Medicine, Nature Communications and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026